Stock listing

Invex Therapeutics Ltd.

Selected listing: IXC · ASX · AUD · AU

Invex Therapeutics Ltd. (ASX:IXC), Health Technology. Latest release Feb 12, 2026: Appendix 4D and Half Year Report.

IXC:ASXAUDAUUpdated October 2, 2026
Invex Therapeutics Ltd. logo
Ticker
ASX:IXC
Asset type
Stock
Sector
Health Technology
Industry
Biotechnology
Exchange
ASX
Currency
AUD

About Invex Therapeutics Ltd.

Invex Therapeutics Ltd. is a public company listed on the Australian market under the ticker IXC. Invex focuses on developing innovative therapies for neurological conditions.

Latest news from Invex Therapeutics Ltd.

Appendix 4D and Half Year Report

February 12, 2026

Quarterly Activities/Appendix 4C Cash Flow Report

January 22, 2026

Reinstatement to Quotation

November 9, 2025

Board and Officer Appointments and Company Address Change

November 9, 2025

Suspension from Official Quotation

November 7, 2025

All Invex Therapeutics Ltd. news →

Research Invex Therapeutics Ltd.

Invex Therapeutics Ltd. company profile

View the public company page for Invex Therapeutics Ltd. on 6ix.

Invex Therapeutics Ltd. news

Read company news and market updates connected to Invex Therapeutics Ltd..

Invex Therapeutics Ltd. investor events

Find investor webinars, events, and replay context for Invex Therapeutics Ltd..